Episode 1 : The Interview of Cytokines Therapy for Alopecia

Clinical Solutions for Female and Youth Hair Loss
 

AesMed has launched a new expert interview series, “The Interview of Cytokines Therapy for Alopecia,” to share practical clinical insights into advanced approaches for hair loss management.

In the first episode, AesMed speaks with Director Jino Kim of New Hair Clinic about the medical value and clinical role of cytokines therapy in contemporary hair loss practice.

Addressing an Unmet Need in Hair Loss Clinics

Hair loss treatment is not limited to middle-aged male patients. An increasing number of women and younger individuals seek professional care for concerns such as reduced hair density, thinning hair, widening part lines, and early-stage hair loss.

However, treatment options for these groups can be limited. Oral medications may not be appropriate for every patient, while surgical procedures may be unsuitable for those in the early stages of hair loss or for patients who prefer less invasive approaches.

During the interview, Director Kim explains how cytokines therapy can help address this clinical gap by providing an additional treatment option for patients who require a more flexible and individualized approach.

The Clinical Value of Cytokines Therapy

Director Kim notes that cytokines therapy has become an important protocol in modern hair loss clinics. Based on his clinical experience, he highlights the immediate improvement in hair strength observed after the application of cytokines ampoules as an encouraging indicator for both practitioners and patients.

He explains that cytokines therapy can be particularly valuable for female and younger patients, for whom conventional medication or surgical treatment may not always be the most appropriate first-line option.

By supporting the scalp and hair follicle environment, cytokines therapy may be incorporated into a broader clinical program that includes accurate diagnosis, scalp assessment, procedural treatment, follow-up evaluation, and home care.

Expanding Treatment Options for Female and Younger Patients

One of the key messages of the interview is the importance of expanding treatment choices according to each patient’s age, condition, level of hair loss, and treatment goals.

Director Kim describes cytokines therapy as a unique clinical alternative that can help fill the gap between conventional medication-based treatment and surgical intervention.

This approach may allow clinics to:

• Provide additional options for patients who are unable or unwilling to take oral medication
• Support patients experiencing early-stage thinning or reduced hair density
• Develop individualized treatment programs for female and younger patients
• Combine professional procedures with scalp care and home-care guidance
• Expand the clinic’s range of non-surgical hair loss management services

AesMed’s Commitment to Evidence-Based Hair Loss Solutions

AesMed is a global bio-brand committed to developing scientifically grounded hair loss solutions in collaboration with medical professionals and clinical experts worldwide.

Through expert interviews, clinical education, and continued research, AesMed aims to provide medical professionals with practical information that can support more systematic and patient-centered hair loss care.

Based on clinical experience, scientific knowledge, and professional collaboration, AesMed will continue to contribute to the development of advanced standards in hair loss management—supporting greater confidence and satisfaction for both clinics and patients.
 

Watch the full interview on the official AesMed YouTube channel:

The Interview of Cytokines Therapy for Alopecia : Episode 1

AesMed Co., Ltd.
Healthy Hair, Healthy Life
Website: www.aesmed.co.kr
YouTube: www.youtube.com/@aesmedkorea
Facebook: www.facebook.com/aesmedkorea